2-溴-3-氯-5-硝基吡啶 | 22353-41-9

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机1,3-偶极化合物 - 烯丙基型1,3-偶极有机化合物
• 中文名称: 2-溴-3-氯-5-硝基吡啶
• 英文名称: 2-bromo-3-chloro-5-nitropyridine
• CAS: 22353-41-9
• 化学式: C₅H₂BrClN₂O₂
• 分子量: 237.44
• InChiKey: VDVNBTTZUJOHJZ-UHFFFAOYSA-N

物化性质

• 熔点：
  62 °C
• 沸点：
  270 °C
• 密度：
  1.936±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  58.7
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  T
• 安全说明：
  S45
• 危险类别码：
  R25
• 海关编码：
  2933399090
• 危险品运输编号：
  UN 2811
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Bromo-3-chloro-5-nitropyridine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-3-chloro-5-nitropyridine
CAS number: 22353-41-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C5H2BrClN2O2
Molecular weight: 237.4

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-溴-3-氯-5-硝基吡啶 在 铁粉 、 溶剂黄146 作用下， 以 水 为溶剂， 反应 2.0h， 以81%的产率得到5-氨基-2-溴-3-氯吡啶
  参考文献：
  名称：

  Chemistry of 3-Hydroxypyridine Part 2: Synthesis of 5,6-Dihalo-3-hydroxypyridines

  摘要：

  本文介绍了从市售的 2-hydroxy-5-nitropyridine 开始，多步骤合成迄今未知的 5,6-二卤-3-羟基吡啶的方法。此外，还探讨了廉价的 2-氨基甲基呋喃（糠胺）在新颖的两步法中制备标题化合物的适用性。

  DOI：

  10.1055/s-1990-26919
• 作为产物：
  描述：

  2-羟基-5-硝基吡啶 在 喹啉 、 盐酸 、 potassium chlorate 、 三溴氧磷 作用下， 反应 2.25h， 生成 2-溴-3-氯-5-硝基吡啶
  参考文献：
  名称：

  Chemistry of 3-Hydroxypyridine Part 2: Synthesis of 5,6-Dihalo-3-hydroxypyridines

  摘要：

  本文介绍了从市售的 2-hydroxy-5-nitropyridine 开始，多步骤合成迄今未知的 5,6-二卤-3-羟基吡啶的方法。此外，还探讨了廉价的 2-氨基甲基呋喃（糠胺）在新颖的两步法中制备标题化合物的适用性。

  DOI：

  10.1055/s-1990-26919

文献信息

• Sustainable Fe–ppm Pd nanoparticle catalysis of Suzuki-Miyaura cross-couplings in water
  作者：Sachin Handa、Ye Wang、Fabrice Gallou、Bruce H. Lipshutz

  DOI：10.1126/science.aac6936

  日期：2015.9.4

  1087 An iron preparation substantially lowers the quantity of palladium needed to catalyze a common reaction that forms C-C bonds. Most of today’s use of transition metal–catalyzed cross-coupling chemistry relies on expensive quantities of palladium (Pd). Here we report that nanoparticles formed from inexpensive FeCl3 that naturally contains parts-per-million (ppm) levels of Pd can catalyze Suzuki-Miyaura

  铁为痕量钯提供动力 钯 (Pd) 是化学催化的支柱。贵金属具有锻造碳-碳 (CC) 键的诀窍。汉达等人。现在报告说，当与铁混合在特定制剂中时，仅百万分之一的 Pd 就足以催化形成 CC 键的 Suzuki 偶联反应。表面活性剂的加入使反应在水中进行。该协议预示着在药物和农用化学品合成中保护 Pd 是个好兆头。科学，这个问题 p。1087 铁制剂显着降低了催化形成 CC 键的常见反应所需的钯量。今天大多数过渡金属催化交叉偶联化学的使用依赖于昂贵数量的钯 (Pd)。在这里，我们报告说，由天然含有百万分之一 (ppm) 水平 Pd 的廉价 FeCl3 形成的纳米粒子可以催化 Suzuki-Miyaura 反应，包括涉及极具挑战性的反应伙伴的情况。纳米胶束用于溶解反应物并将反应伙伴传递给 Fe-ppm Pd 催化剂，从而形成碳-碳键。新形成的催化剂可以在环境温度下分离和储存。含有表面活性剂和催化剂
• [EN] DI-SUBSTITUTED PYRAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASES<br/>[FR] COMPOSÉS DE PYRAZOLE DI-SUBSTITUÉS POUR LE TRAITEMENT DE MALADIES
  申请人：FGH BIOTECH INC

  公开号：WO2017190086A1

  公开（公告）日：2017-11-02

  Provided herein are compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds and compositions in treating a condition, disease, or disorder associated with abnormal activation of the SREBP pathway, including metabolic disorders such as obesity, cancer, cardiovascular disease, and nonalcoholic fatty liver disease (NAFLD) wherein the compound is according to Formula (I).

  本文提供了化合物、包含这些化合物的药物组合物，以及使用这些化合物和组合物治疗与SREBP途径异常激活相关的疾病、疾病或紊乱的方法，包括代谢紊乱如肥胖、癌症、心血管疾病和非酒精性脂肪肝病（NAFLD），其中该化合物符合式（I）。
• [EN] CYCLIC COMPOUNDS AND METHODS OF USING SAME<br/>[FR] COMPOSÉS CYCLIQUES ET LEURS PROCÉDÉS D'UTILISATION
  申请人：SCHRODINGER INC

  公开号：WO2021134004A1

  公开（公告）日：2021-07-01

  The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases, such as cancer, autoimmune disorders, and inflammatory disorders.

  本申请涉及以下式（I）的化合物及其药用盐，其在此处定义为MALT1抑制剂。本申请还描述了包括式（I）化合物及其药用盐的药物组合物，以及使用这些化合物和组合物治疗疾病（如癌症、自身免疫性疾病和炎症性疾病）的方法。
• [EN] COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY<br/>[FR] COMPOSÉS ET COMPOSITIONS POUR LE TRAITEMENT DES ÉTATS ASSOCIÉS À UNE ACTIVITÉ DE STING
  申请人：IFM DUE INC

  公开号：WO2022015957A1

  公开（公告）日：2022-01-20

  This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes (STING). Said chemical entities are useful, e.g., for treating a condition, disease or disorder in which increased (e.g., excessive) STING activation (e.g., STING signaling) contributes to the pathology and/or symptoms and/or progression of the condition, disease or disorder (e.g., cancer) in a subject (e.g., a human). This disclosure also features compositions containing the same as well as methods of using and making the same.

  本公开涉及化学实体（例如，一种化合物或一种药用可接受的盐，和/或水合物，和/或共晶体，和/或化合物的药物组合），其抑制（例如，对抗）干扰素基因激活剂（STING）。所述化学实体可用于治疗在其中增加（例如，过度）STING激活（例如，STING信号传导）导致病理和/或症状和/或病情进展的疾病或紊乱的情况，例如癌症，在受试者（例如，人类）中。本公开还涉及含有相同化学实体的组合物，以及使用和制备相同的方法。
• CARBOXAMIDE DERIVATIVES AS PESTICIDAL COMPOUNDS
  申请人：BAYER ANIMAL HEALTH GMBH

  公开号：US20160221950A1

  公开（公告）日：2016-08-04

  Disclosed are compounds of formula (I) which possess pesticidal, especially nematicidal properties wherein in the structural elements have the meaning as indicated in the description.

  本发明涉及一种具有杀虫特别是杀线虫作用的化合物，其化学式为（I），其中所述结构元素的含义如描述中所示。